Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc W Manseau

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 28, 2015
Cannabinoids and Schizophrenia: Risks and Therapeutic PotentialMarc W Manseau, Donald C Goff
Schizophrenia Research|January 12, 2021
Symptomatology and neurocognition among first-episode psychosis patients with and without cannabis use in the three months prior to first hospitalizationLeah G Pope, Marc W Manseau, Mary E Kelley, et al.
Community Mental Health Journal|January 6, 2020
Chronic Disease Screening and Prevention Activities in Mental Health Clinics in New York State: Current Practices and Future OpportunitiesMichael T Compton, Marc W Manseau, Heather Dacus, et al.
The American Journal of Drug and Alcohol Abuse|November 1, 2016
Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency settingAdriana M Joseph, Marc W Manseau, Monique Lalane, et al.
Substance Use & Misuse|February 4, 2017
Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric Emergency SettingMarc W Manseau, Amit Rajparia, Adriana Joseph, et al.
Psychiatric Services (Washington, D.C.)|September 5, 2019
Major Mental Illness as a Risk Factor for IncarcerationDonna Hall, Li-Wen Lee, Marc W Manseau, et al.
AIDS and Behavior|December 7, 2005
MSM in HIV-prevention trials are sexual partners with each other: An ancillary study to the EXPLORE interventionMatthew J Mimiaga, Steven A Safren, Dana Jones Benet, et al.
Implementation Science : IS|January 8, 2021
A facilitation model for implementing quality improvement practices to enhance outpatient substance use disorder treatment outcomes: a stepped-wedge randomized controlled trial study protocolMegan A O'Grady, Patricia Lincourt, Belinda Greenfield, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|September 18, 2012
Opportunities to enhance prevention-related competencies in graduate medical education in psychiatry: a position statement of the Prevention Committee of the Group for the Advancement of PsychiatryRuth S Shim, Rebecca A Powers, Christopher Oleskey, et al.
Community Mental Health Journal|October 21, 2020
Screening and Treatment of Tobacco Use Disorder in Mental Health Clinics in New York State: Current Status and Potential Next StepsAdria Zern, Michael Seserman, Heather Dacus, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 28, 2015
Cannabinoids and Schizophrenia: Risks and Therapeutic PotentialMarc W Manseau, Donald C Goff
Schizophrenia Research|January 12, 2021
Symptomatology and neurocognition among first-episode psychosis patients with and without cannabis use in the three months prior to first hospitalizationLeah G Pope, Marc W Manseau, Mary E Kelley, et al.
Community Mental Health Journal|January 6, 2020
Chronic Disease Screening and Prevention Activities in Mental Health Clinics in New York State: Current Practices and Future OpportunitiesMichael T Compton, Marc W Manseau, Heather Dacus, et al.
The American Journal of Drug and Alcohol Abuse|November 1, 2016
Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency settingAdriana M Joseph, Marc W Manseau, Monique Lalane, et al.
Substance Use & Misuse|February 4, 2017
Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric Emergency SettingMarc W Manseau, Amit Rajparia, Adriana Joseph, et al.
Psychiatric Services (Washington, D.C.)|September 5, 2019
Major Mental Illness as a Risk Factor for IncarcerationDonna Hall, Li-Wen Lee, Marc W Manseau, et al.
AIDS and Behavior|December 7, 2005
MSM in HIV-prevention trials are sexual partners with each other: An ancillary study to the EXPLORE interventionMatthew J Mimiaga, Steven A Safren, Dana Jones Benet, et al.
Implementation Science : IS|January 8, 2021
A facilitation model for implementing quality improvement practices to enhance outpatient substance use disorder treatment outcomes: a stepped-wedge randomized controlled trial study protocolMegan A O'Grady, Patricia Lincourt, Belinda Greenfield, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|September 18, 2012
Opportunities to enhance prevention-related competencies in graduate medical education in psychiatry: a position statement of the Prevention Committee of the Group for the Advancement of PsychiatryRuth S Shim, Rebecca A Powers, Christopher Oleskey, et al.
Community Mental Health Journal|October 21, 2020
Screening and Treatment of Tobacco Use Disorder in Mental Health Clinics in New York State: Current Status and Potential Next StepsAdria Zern, Michael Seserman, Heather Dacus, et al.
Pageof 2